Immunic is trading at $9.81, up 5.03%, with no clear company-specific catalyst identified for the September 28 move.
- The latest surfaced company news was dated September 23; a September 28 Form 4 headline does not establish a reason for the gain.
- Major U.S. indexes were lower, so the available market context does not explain Immunicβs rise. The available sources do not establish another cause.